Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering

Jacobs, one of the world's largest engineering and environmental consultancy groups, has more than 70,000 employees globally

SYDNEY, Australia and MINNEAPOLIS, May 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio's Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions.

Through the Mental Health Check-In, companies can offer employees an end-to-end mental health program, direct to their devices, to see how the mind and body are tracking. It's a personalized, private, and objective way to see the unseeable: mental health issues in the workplace.

Employees are provided the opportunity to confidentially check-in on their mental health and receive personalized confidential results from both an objective biometric screening in conjunction with a 12-minute subjective survey. Employers receive a dashboard providing de-identified, amalgamated data on the well-being of their workforce leveraging both the subjective and objective metrics. Employees then have the option to connect their wearable devices, such as Apple Watch, Garmin, and Fitbit, collect heart rate and sleep data.

The first-phase contract extends Medibio's engagement with Jacob's beyond Asia Pacific, to now encompass over 8,000 employees across Asia Pacific, India, the Middle East and Europe. The Check-In will be rolled out to Jacobs' European leadership team alongside the Asia Pacific and Middle Eastern workforces and is projected to generate first-stage revenue of approximately $50,000 for the initial four-week program. Services, including consultancy and delivery of ongoing mental health interventions and programs, will be billed as provided.

The correlation of ANS biometrics and mental health has been the focus of the company for over 20 years. Especially while sleeping, our bodies reflect our mental state through the performance of the autonomic nervous system. Medibio's technology platform detects dysfunction within the areas of the body regulated by the ANS, and through proprietary data processing and algorithms, the technology correlates these anomalies to different mental health conditions. It is a profound discovery that for the first time provides a tangible, objective understanding of mental health.